Juergen Dembowski

Title: Juergen Dembowski: Innovator in Pharmaceutical Technology

Introduction

Juergen Dembowski is a notable inventor based in Goellheim, Germany. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the efficacy and safety of pharmaceutical active compounds.

Latest Patents

Dembowski holds a patent for a novel delayed-release form for pharmaceutical active compounds. This invention is characterized by a core containing the active compound and a diffusion-inhibiting, adhesive coating layer. The coating has a thickness ranging from 0.01 to 10 micrometers and consists of a chemical network applied through a plasma-assisted chemical deposition process. This innovative approach aims to improve the release profile of pharmaceutical compounds, ensuring better therapeutic outcomes.

Career Highlights

Juergen Dembowski is associated with BASF Aktiengesellschaft, a leading global chemical company. His role at BASF has allowed him to work on cutting-edge research and development projects that push the boundaries of pharmaceutical science. His expertise in the field has led to advancements that benefit both the industry and patients.

Collaborations

Dembowski has collaborated with esteemed colleagues, including Klaus Harth and Ernst Flaig. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, ultimately leading to the successful development of new technologies.

Conclusion

Juergen Dembowski's contributions to pharmaceutical technology exemplify the impact of innovative thinking in the field. His patent for a delayed-release form of pharmaceutical active compounds showcases his commitment to improving drug delivery systems. Through his work at BASF and collaborations with fellow researchers, Dembowski continues to influence the future of pharmaceutical science.